We speculate that the genomic alterations in the ROC3 tumor cells might lead to the productive expression of neoantigens promoting the infiltration of CD11c+ dendritic cells, but these cells can be inactivated by the expression of immune checkpoints and Tregs. This evidence concerns the gene ITGAX and neoplasm.